Table 1.
Characteristic | Study Population No. (%)a |
---|---|
No. | 757 |
Demographics | |
Age at randomization, years | |
No. | 757 |
Median (Q1, Q3) | 67 (61, 72) |
Follow-up time, years | |
No. | 757 |
Median (Q1, Q3) | 3 (2, 5) |
Female sex | 144/757 (19%) |
Race | |
White | 634/755 (84%) |
Black | 84/755 (11%) |
Asian | 20/755 (3%) |
Other or multiple ethnic groups | 17/755 (2%) |
Hispanic or Latino ethnicity | 38/750 (5%) |
Cigarette smoking | |
Current smoker | 85/757 (11%) |
Former smoker | 412/757 (54%) |
Never smoker | 260/757 (34%) |
Randomized to invasive | 368/757 (49%) |
Randomized to conservative | 389/757 (51%) |
Clinical history | |
Diabetes | 344/757 (45%) |
Insulin treated | 141/341 (41%) |
Non-insulin treated or diet controlled | 200/341 (59%) |
Hypertension | 644/755 (85%) |
BMI, kg/m2 | |
No. | 754 |
Median (Q1, Q3) | 29 (26, 33) |
Obese, BMI ≥30 kg/m2 | 343/754 (45%) |
eGFR, mL/min/1.73 m2 | |
No. | 757 |
Median (Q1, Q3) | 74 (58, 90) |
eGFR <60 ml/min/1.73 m2 | 206/757 (27%) |
Baseline dialysis | 49/757 (6%) |
Left ventricular ejection fraction | |
No. | 757 |
Median (Q1, Q3) | 60 (54, 65) |
Left ventricular ejection fraction <45% | 52/756 (7%) |
Prior myocardial infarction | 175/754 (23%) |
Prior PCI | 203/757 (27%) |
Prior CABG | 43/757 (6%) |
History of heart failure | 34/757 (4%) |
History of cerebrovascular disease | 85/756 (11%) |
History of peripheral artery disease | 45/755 (6%) |
Family history of premature CAD | 209/645 (32%) |
Ischemia severity by stress testing | |
Severe | 329/756 (44%) |
Moderate | 355/756 (47%) |
Mild/none | 69/756 (9%) |
Uninterpretable | 3/756 (0%) |
CCTA findings | |
CCTA performed | 508/757 (67%) |
Any obstructive disease ≥70% stenosis by CCTA | 392/508 (77%) |
Multivessel disease ≥70% stenosis by CCTA | 185/508 (36%) |
Vessels ≥70% stenosis by CCTA | |
0 | 60/508 (12%) |
1 | 134/508 (26%) |
2 | 84/508 (17%) |
3 or more | 65/508 (13%) |
Non evaluable | 165/508 (32%) |
Continuously measured variables are summarized with the median, 25th percentile (Q1), and 75th percentile (Q3).